Genetic aberrations involving CIITA were also more common in EBV+ DLBCL, with 23% break-apart and 6% deletion events, compared with 2% break-apart and 0% deletion events in EBV-negative DLBCL [96]. This evidence concerns the gene CIITA and diffuse large B-cell lymphoma.